USRE39664E1 - Lateral flow chromatographic binding assay device - Google Patents

Lateral flow chromatographic binding assay device Download PDF

Info

Publication number
USRE39664E1
USRE39664E1 US08561215 US56121595A USRE39664E US RE39664 E1 USRE39664 E1 US RE39664E1 US 08561215 US08561215 US 08561215 US 56121595 A US56121595 A US 56121595A US RE39664 E USRE39664 E US RE39664E
Authority
US
Grant status
Grant
Patent type
Prior art keywords
sample
zone
chromatographic
reaction
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08561215
Inventor
Julian Gordon
Charles Stuart Gredell Pugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Switzerland GmbH
Original Assignee
Alere Switzerland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Abstract

The present invention relates to improved specific binding assay devices comprising a chromatographic medium including a reaction site at which a specific binding reagent is immobilized, a sample application well located adjacent to the chromatographic medium and offset upstream from the reaction site, and liquid absorption blotter offset downstream from the reaction site.

Description

This application is a continuation of application Ser. No. 08/322,027, filed Oct. 12, 1994 which is a continuation of application Ser. No. 07/942,493, filed Sep. 9, 1992.

BACKGROUND OF THE INVENTION

The present invention relates generally to methods and devices for carrying out specific binding assays. More specifically, the invention relates to methods for the use of chromatographic transport for the movement of reagents and reactive sample components.

The use of specific binding assays has been found to be of great value in a variety of clinical and other applications. Such assays involve the detection and determination of an analyte substance which is a member of a specific binding pair consisting of a ligand and a receptor. The ligand and the receptor are related in that the receptor specifically binds to the ligands, being capable of distinguishing the ligand from other sample constituents having similar characteristics. Specific binding assays include immunological assays involving reactions between antibodies and antigens, DNA and RNA hybridization reactions and other specific binding reactions such as those involving hormone and other biological receptors. Specifically binding assays may be practiced according to a variety of formats well known in the art. Such assays include competitive binding assays, “direct” and “indirect” sandwich assays and agglutination assays.

Because the results of specific binding reactions are generally not directly observable, various techniques have been devised for labelling one member of the specific binding pair in order that the binding reaction may be indirectly observed. Useful labels include radiolabels, chromophores and fluorophores the presence of which may be detected by means of radiation detectors, spectrophotometers or the naked eye. Where members of a specific binding pair are tagged with an enzyme label, their presence may be detected by the enzymatic activation of a reaction system including a signal generating substrate/cofactor group wherein a compound such as a dyestuff, is activated to produce a detectable signal.

Specific binding assay devices are known in the art comprising vertically arranged elements including (a) a porous capture material which is impregnated at a reaction site with member of a specific binding pair such as an antibody or an antigen; (b) a removable prefilter disposed above the capture material and (c) a blotter disposed below the capture material. A sample liquid such as blood, serum or other biological fluid is added to the device wherein the prefilter removes particulates and other impurities from the sample which would otherwise be trapped on top of the specific binding capture material. Analyte substances within the sample are trapped by means of specific binding reactions with their specific binding partners on the capture material. Non-analyte components of the sample solution pass through the capture material and are absorbed by the blotter. Wash steps may be carried out to remove non-analyte components from the capture material and additional reagents such as enzyme substrates, cofactors and dye precursors, may be added to the capture material in order to indicate the presence or absence of analyte at the reaction site. The prefilter must then be removed in order that the presence or absence of analyte at the reaction site may be virtually determined. Such assay devices are rapid and generally reliable but suffer from limitations in capture efficiency and sensitivity because most of the analyte in the sampling material flows around rather than through the reaction site on the capture material.

Various disclosures are of interest to the present application. Tom, et al., U.S. Pat. No.4,366,241 discloses an immunoassay device comprising a relatively small test zone including a specific binding reagent, and a relatively large absorbing zone in liquid receiving relationship with said immunosorbing zone. Immunoassays for determining the presence of an analyte material are carried out by contacting the assay device with a sample solution, a solution containing enzyme labelled specific binding material and a solution containing an enzyme catalyzed signal system. The solutions migrate through the immunosorbing zone into the liquid absorbing zone and the presence of analyte in the sample material is indicated by enzyme activation of the signal system.

Deutsch, et al., U.S. Pat. Nos. 4,094,647, 4,235,601 and 4,361,537 relate to immunological and other types of specific binding assays wherein reagents are transported by chromatographic solvent transport. According to one embodiment, a radiolabeled competitive binding assay kit comprises a strip capable of transporting a developing liquid by capillarity having a first zone for receiving a sample, a second zone impregnated with a first reagent capable of being transported by the developing liquid and a third zone impregnated with a second reagent. In addition, the devices comprise a measuring zone and a retarding element which may be either the second reagent or the material of the strip. The first reagent is capable of reacting with one of the group consisting of (1) the sample, (2) the sample and the second reagent, and (3) the second reagent in competition with the sample, to form a product in an amount dependent on the characteristic being determined. A sample is contacted with the first zone and the strip is then dipped into the developing liquid to bring about transport of the sample and the first reagent to form the reaction product. The retarding element shows transport of either the product or the first reagent (the moving reagent) to spacially separate the two and the amount of the moving element is then measured at the measurement location.

Also of interest to the present invention is the disclosure of co-owned and copending U.S. patent application Ser. No. 912,878 filed Sept. 29, 1986 by Gordon, et al. U.S. Pat. No. 4,960,691, which is hereby incorporated by reference and which relates to devices for conducting specific binding assays utilizing the sequential chromatographic transport of analyte and reagent materials. Wash and addition steps are inherently carried out and liquid “microcircuitry” can be programmed to carry out a variety of multistep procedures and to avoid the premature mixing of sample materials and reagents. Specifically, the Gordon, et al., sequential transport application relates to devices which comprise a test strip for the detection of an analyte in a sample comprising a length of chromatographic material having the capacity for rapid chromatographic solvent transport of non-immobilized reagents and reactive sample components by means of a selected chromatographic solvent.

Of further interest to the present invention are the disclosures of Piasio, et al., U.S. Pat. No. 4,255,575 and Litman, et al., U.S. Pat. No. 4,391,904. These references relate to specific binding assay methods generally and disclose immobilization of enzyme substrates buffers and cofactors on solid phase matrices.

SUMMARY OF THE INVENTION

The present invention relates to devices and methods for determining the presence or amount of an analyte substance in a sample by means or one or more specific binding reactions. The devices include, a chromatographic medium having capillarity and the capacity for chromatographic solvent transport of one or more reactive sample components and non-immobilized reagents including a reaction site at which is present an immobilized reagent capable of binding a member from the group consisting of the analyte substance and a labelled specific binding material. The devices also include a sample application means located adjacent to the chromatographic medium and offset upstream from the reaction site, and a liquid absorption means offset downstream from the reaction site. A method for use of the device to determine the presence or amount of an analyte substance in sample includes the steps (a) applying a volume of a sample to be analyzed to the sample application means whereby the sample is transported along the chromatographic medium through the reaction site to the liquid absorption means, (b) contacting the labelled specific binding material to the reaction site, (c) removing unbound sample materials and unbound labelled specific binding materials from the reaction site and (d) determining the presence or amount of labelled specific binding material immobilized at the reaction site as an indication of the presence or amount of the analyte substance in the sample.

The unbound sample materials and unbound labelled specific binding materials may be removed from the reaction site by means of a wash step wherein a wash solution is applied to the reaction site, preferably by application through the sample application means. Alternatively, if the labelled binding material is sufficiently dilute, a wash step is not always necessary.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 depicts a perspective view of a device according to the present invention.

FIG. 2 depicts a top view of the device depicted in FIG. 1.

FIG. 3 depicts a view along line 33 of the device depicted in FIG. 2.

DETAILED DESCRIPTION

The present invention provides improved methods and devices for the practice of chromatographic specific binding assay techniques. Devices according to the invention are characterized by a high capture efficiency which is particularly advantageous in the use of the invention for diagnosis of pediatric and geriatric patients where the volume is of sample fluids obtainable from such patients may be limited. This high capture efficiency results from the chromatographic transport of sample and other reactive materials laterally through the reaction site which forces the materials to flow through a length of chromatographic media containing specific binding agents rather than through or around a narrow thickness of impregnated medium.

The devices are suitable for analysis of samples with heavy loads of particulate matter without the necessity of a prefilter. Particulate matter does not interfere with analyte determination at the location of the reaction site, but instead accumulates at the interface of the sample application means and the chromatographic material. Nevertheless, prefilters, and particularly non-removable ones, may be used and fitted into sample application means where samples comprise especially heavy loads of particulate matter, for example, whole blood.

The devices of the present invention comprise a chromatographic medium with a reaction site, a sample application means located adjacent to the medium and offset upstream from the reaction site and a liquid absorption means located downstream from the reaction site. Present at the reaction site is an immobilized reagent capable of binding a member from the group consisting of said substances and a labelled specific binding material. The chromatographic medium and sample application and liquid absorption means are preferably disposed in a holder. Sample materials and reagents are added together or sequentially to the sample application means, which may comprise an area offset from the reaction site, a well, an absorbent pad, or volumetric delivery device in contact with the chromatographic medium. Preferably, the sample application means is a well or absorbent pad, such as may be fashioned from blotter material. The sample materials and reagents are absorbed into the chromatographic medium and are chromatographically transported along the medium and laterally through the reaction site. Analyte substance and reagent materials may be immobilized by a specific binding reaction at the reaction site while non-analyte sample components and non-immobilized reagents are transported through the chromatographic medium to the liquid absorption means located downstream from the reaction site.

Referring to the drawings, FIGS. 1 through 3, depict a device (10) for the detection of an analyte in a sample liquid comprising an upper housing portion (11), a lower housing portion (12), a length of chromatographic medium (13) with a first end (14) at which chromatographic solvent transport begins, a second end (15) at which chromatographic solvent transport ends and a reaction site (16) at which is immobilized a reagent capable of binding a member from the group consisting of the analyte substance and a labelled specific binding material. The device (10) further comprises a backing strip (17) adjacent to the chromatographic medium (13), a sample well (18) defined by the upper housing portion (11) adjacent to the first end (14) of the chromatographic medium (13) and a blotter material (19) downstream from the reaction site (16) and adjacent to the second end (15) the chromatographic medium (13).

According to one procedure for use of the device (10) to perform sandwich-type assays, a volume of a sample to be tested for the presence of an analyte substance is added to the sample well. The sample material is absorbed into the chromatographic medium (13) where it begins to flow toward the second end (15). The sample material containing the analyte substance, if any, flows through the reaction site (16) at which a reagent is immobilized which is capable of specifically binding with any analyte substance so as to immobilize it at the reaction site (16). Non-analyte sample materials continue to flow through the chromatographic medium (13) toward the second end (15) where they are absorbed by the blotter material (19).

When transport of the sample material from the sample well (18) to the blotter material (19) is complete a labelled reagent material capable of specifically binding with the analyte substance is added to the sample well (18) such that it is absorbed by the chromatographic medium (13) and transported through the reaction site (16) to the second end (15) of the medium where it is absorbed by the blotter material (19). When any of the analyte substance is immobilized at the reaction site (16) the labelled reagent material reacts with the analyte substance and is also immobilized. Where the reagent material is labelled with a radiolabel, a chromophore or a fluorophore the presence of the labelled material and hence the analyte substance may be detected at the reaction site. Where the reagent material is enzyme-labelled, additional reagents such as enzyme substrates, cofactors and dye precursors may be added to the sample well (18) or directly to the reaction site (16) in order to indicate the presence of the analyte substance.

According to two alternative embodiments, the labelled specific binding material may be included or dried in the chromatographic medium, upstream of reaction site or in the absorbent material of the sample application means such that it is reconstituted by addition of the sample.

The device (10) according to FIGS. 1 through 3 may also be modified to perform competition-type specific binding assays. According to one such method, the labelled specific binding reagent may be selected to compete with the analyte substance for binding with the reagent immobilized at the reaction zone (16) which is capable of binding with both. The quantity of the analyte substance present in the sample will determine the preportion of a predetermined amount of labelled specific binding material that binds at the reaction site (16). Adjustments Of of the quantity and/or binding affinity of the labelled specific binding material can be made in order to determine the quantity of analyte present in the sample.

Various other specific binding assays may be carried out on the devices of the present invention. As an example, the chromatographic medium may be impregnated at additional reaction sites with various immobilized specific binding agents. Such additional reaction sites may be used for the detection of additional analyte substances or may be used, as in a comparison-type assay to quantify the amount of analyte substance present in a sample. Additional reaction zones may be used to capture substances that interfere with accurate determination of the analyte.

The chromatographic medium may be impregnated with other reagents and materials including dye compounds, enzyme substrates, coenzymes and cofactors which react with enzyme labels to produce color signals as is well known in the art. According to one aspect of the present invention, where the labelled specific binding agents are enzyme-labelled the enzyme label being characterized in that its presence may be determined by reaction with members of a signal generating substrate/cofactor group, a first member of the signal generating substrate/cofactor group may be immobilized at a reaction site on the chromatographic medium. A second member of the substrate/cofactor group may be added at an appropriate time to activate the signal generating system if an enzyme label is present. By preimpregnating the reaction site with a member of the signal generating substrate/cofactor group, an additional step is avoided and problems relating to the instability or insolubility of substrates, cofactors and dye precursors when stored together are avoided. Moreover, certain members of the signal generating group of compounds may have low chromatographic mobility with the result that pre-impregnation at the reaction site is particularly preferred.

The devices may be housed singly, in pairs, or in multiple configurations. The housing should preferably be watertight to prevent leakage and may be manufactured from a variety of inert materials, with polymer materials being preferred for their ease of fabrication. The sample well should be of sufficient volume to contain any required amount of sample or reagents to be used with the invention. Where the liquid absorption means is enclosed within the housing of the device, it should be provided with sufficient volume that sample, wash, and reagent materials applied to the device during assay procedures may all be absorbed. According to a preferred embodiment of the present invention wherein the chromatographic media is a strip of nitrocellulose material 0.4 cm wide, sample and reagent volumes ranging from 10 μl to 150 μl are suitably accommodated.

The reaction site is located downstream from the sample application means and is visible to view from either side, either being unenclosed or covered with a transparent material. The reaction site is preferably unenclosed, thus facilitating observation of the presence or absence of signals from the site and also allowing the addition of reagents and/or wash solutions to the reaction site.

The liquid absorption means located downstream from the reaction site absorbs sample materials, reagents and wash solutions and thus allows chromatographic transport of sample and other materials from the first end of the chromatographic medium through the reaction site to the second end of the medium. Without such absorption chromatographic transport would cease and the efficiency advantage resulting from the lateral flow of sample through the reaction site would be lost.

The liquid absorption means can include the chromatographic medium itself wherein sample and reagent materials are transported and absorbed by an extended length of the medium. A particularly preferred aspect of the invention is that wherein the liquid absorption means is located adjacent to the chromatographic medium and is offset downstream from the reaction site. Locating the absorption means adjacent to the chromatographic medium provides additional absorption capacity. Offsetting the absorption means downstream from the reaction site ensures that sample materials, and all other materials introduced upstream of the reaction site flow primarily laterally and not vertically through the reaction site.

The absorption means may consist of an extended length of chromatographic medium but preferably consists of a quantity of blotter material. Cellulosic blotter materials derived from wood pulp or cotton are suitable. The blotter material need not have dimensions similar to those of the chromatographic medium and is generally wider and thicker than the chromatographic medium. The blotter need only be adjacent to the chromatographic medium such that fluid from the chromatographic medium can flow into the blotter. A particularly preferred material is James River Type 52 point blotter material (James River Paper Co., Inc., Richmond, Va.). The absorption means preferably must be capable of absorbing the entire volume of sample material and is preferably capable of absorbing the additional reagents and doing so rather rapidly.

Chromatographic media useful with the present invention include those chromatographic substrate materials having capillarity and the capacity for chromatographic solvent transport of non-immobilized reagents and sample components. The chromatographic media used with the invention are preferably in the form of strips. While a wide variety of chromatographic materials such as woven and non-woven fibrous materials used for paper chromatography are suitable for use with the invention, the use of microporous or microgranular thin layer chromatography substrates is particularly preferred as the use of such materials improves the speed and resolution of the assays according to the invention. The materials should preferably be inert and generally not react physically or chemically with any of the sample components, reagents buffers or reaction products. Co-owned and copending U.S. patent application Ser. No. 912,878 filed Sept. 29, 1986 U.S. Pat. No. 4,960,691 and U.S. patent application Ser. No. 072,459 filed July 13, 1987 Pat. No. 5,120,643, the disclosure of which are hereby incorporated by reference, disclose a wide variety of suitable chromatographic substrate materials. Particularly preferred, however, is the use of a microporous nitrocellulose material with a pore size of 5 μm designated Type SMWP (Millipore Corp., Bedford, Massachusetts).

Because the chromatographic media of the device is preferably chemically inert, it may have to be activated at any reaction site where it is desired to immobilize a specific binding reagent against solvent transport. Various methods will be required to render the reagent immobilized according to the particular chemical nature of the reagent. Generally, when the media is nitrocellulose or a mixed nitrocellulose ester, no special chemical linkage is required for the immobilization of reagents. Various techniques may be used for other materials and reagents which include functionalization with materials such as carbonyldiimidazole, glutaraldehyde or succinic acid, or treatment with materials such as cyanogen bromide. Other suitable reactions include treatment with Schiff bases and borohydride for reduction of aldehyde, carbonyl and amino groups. DNA, RNA and certain antigens may be immobilized against solvent transport by baking onto the chromatographic material. Baking may be carried out at temperatures ranging from about 60° C. to about 120° C. for times varying from about five minutes to about 12 hours, but preferably at about 80° C. for about two hours.

Specific binding reagents useful with the present invention would be readily identifiable to one of skill in the art and include those materials which are members of a specific binding pair consisting of a ligand and a receptor. The ligand and receptor are related in that the receptor specifically binds to the ligands, being capable of distinguishing the ligand from other materials having similar characteristics. The methods and devices according to the present invention are particularly useful in the practice of immunological assay techniques where the specific binding reagents are antigens and antibodies including antibody fragments and synthetic antibodies. Specific binding materials such as avidin, biotin, strepatavidin and antibiotin may also be labelled and utilized in specific binding chromatographic assays according to the invention. The methods, kits and devices may also prove useful in the practice of DNA and RNA hybridization assays and other specific binding assays such as those involving receptors for hormones or other biologically active agents.

Blocking agents useful in preparation of devices for the specific binding of the present invention are those agents capable of blocking excess binding sites on the chromatographic media which might hinder chromatographic solvent transport of sample materials or reagents of the invention. In the construction of devices of the present invention, the chromatographic medium is impregnated with the reagent to be immobilized at the location desired. Once the reagent has been immobilized at the desired site, the strip is then preferably processed so as to block excess binding sites for other reagents or sample materials. Particularly suitable is the use of blocking solutions comprising proteins such as casein, gelatin, albumin or total serum. Such proteins are selected to not interfere with or cross-react with reagent materials of the assays. Blocking of the sites may preferably be conducted by dipping the chromatographic substrate materials in a solution of 0.2% casein in physiological saline and air drying the strip materials. Other methods include dipping in solutions of 0.1% gelatin or 0.1% bovine serum albumin followed by air drying of the substrate materials.

EXAMPLE 1

According to this example, sandwich-type immunoassay devices for the detection of Hepatitis B surface antigen (HBsAg) were constructed and used. Microporous nitrocellulose material with a thickness of approximately 0.15 mm and a pore size of 5μm (Millipore SMWP) was laminated to Mylar and adhesive (Monokote, Top Flite Models, Inc., Chicago, Ill.) at 60° to 65° C. in a film dryer apparatus. The membrane and backing was cut to strips 0.4 cm wide and 2.5 cm long. Anti-HBsAg antibodies (Abbott Laboratories, North Chicago, Ill.) (0.1-0.2 μl, 1.5 mg/ml) were applied to the reaction sites and incubated under ambient conditions for 15 minutes. Non-specific binding sites on the chromatographic medium were then blocked and cosubstrate bound by incubation for ten minutes at ambient temperature with a solution comprising 0.1% fish gelatin, 1% sucrose and 0.14 mg/ml nitro blue tetrazolium in 10 mM Tris and 150 mM NaCl (pH 7.6). The strips were then dried at 40° C. for about one hour and stored at ambient in the presence of a desiccant. Devices generally similar to the device of FIG. 1 through 3 were fashioned utilizing the impregnated strips and James River 52 point blotter material (1.0 cm by 2.4 cm) which was placed above the second end of the strips to function as a liquid absorption means.

To the sample application well of each test device was added a 30 μl sample of decalcified plasma which had been spiked with varying concentrations of HBsAg. After the sample had soaked into the first end of the nitrocellulose material, and had been transported through the reaction site to the second end of the nitrocellulose material, been absorbed by the blotter material a 15 μl aliquot of biotin labelled Anti-HBsAg antibodies (1 μg/ml) was added to each sample well. After this solution was transported through the device, a 15 μl aliquot of alkaline phosphatase labelled antibiotin (2 μg/ml) (Abbott Laboratories, North Chicago, Ill.) was added to each sample well and reaction sites were twice washed by addition to each sample well of 15 μl of wash solution comprising 1% Triton X 100 Triton X 100® brand of octylphenoxypolyethoxy ethanol nonionic detergent Tris buffered saline solution. A 15 μl aliquot of developing solution comprising 0.5 mg/ml bromochloroindolylphosphate, 0.1 mg/ml MgCl2 and 1% 2-amino-2-methyl propanol (pH 9.8) was then added to each sample well and a color reaction was allowed to develop for five minutes before the reaction was inhibited by addition of 15 μl of a 10 mM ethylene diamine tetraacetic acid (EDTA) solution. Sample solutions containing no HbsAg produced no signal, the reaction site was white. Sample solutions containing as little as 0.1 ng/ml HbsAg produced readily visible blue-gray spots at the reaction site. The total assay time was 25 minutes.

EXAMPLE 2

According to this example, sandwich-type immunoassay devices for the detection of HbsAg were constructed and used wherein the labelled specific binding material is labelled with colloidal gold particles according to the method of co-owned and copending U.S. Ser. No. 072,459 U.S. Pat. No. 5,120,643. The device and materials used were identical to that described according to Example 1, with the exception that nitro blue tetrazolium was omitted from the blocking solution.

To the sample well of each device was added a 50 μl sample of recalcified plasma which had been spiked with varying amounts of HBsAg. After the sample had soaked into the first end of the nitrocellulose material, a 50 μl aliquot of anti-HBsAg antibodies labelled with 40 nm colloidal gold particles adsorbed at 5 μg/ml (Abbott Laboratories) was added to each sample well. The total time for the assay was 15 minutes. Sample solutions containing no HBsAg produced no signal over background. Sample solutions as little as 1.0 ng/ml of HBsAg produced visible purple spots at the reaction site. No wash step was required since the antibody gold particles were sufficiently dilute.

Numerous modifications and variations in practice of the invention are expected to occur to those skilled in the art upon consideration of the foregoing descriptions of preferred embodiments thereof. It is well within the skill in the art to practice the present invention according to a wide variety of methods and formats. Consequently, only such limitations should be placed on the invention as appear in the following claims.

Claims (16)

1. A test device for determining the presence or amount of an analyte substance in a sample by means of one or more specific binding reactions comprising:
a bibulous chromatographic medium which extends throughout said device and is free of chromatographic transport-facilitating agent, defining a flowpath having capillarity and the capacity for chromatographic solvent transport of one or more reactive sample components and non-immobilized reagents; said chromatographic medium comprising (1) a prefiltering zone; (2) a reaction site zone disposed downstream from said prefiltering zone at which is present containing an immobilized reagent capable of binding which specifically binds a member selected from the group consisting of said analyte substance and a labeled specific binding material, and at which the presence or amount of immobilized specific binding material, may be is capable of being detected; and (3) a downstream zone free of said immobilized reagent disposed downstream from said reaction site zone,
a sample application means selected from the group consisting ofa single undivided well and an absorbent paddefined by a housing element comprising an upper and lower portion; wherein said upper portion defines the spatial boundaries of said well and said lower portion comprises a portion of said chromatographic medium which is upstream of said prefiltering zone, said well having sufficient capacity to hold a volume of sample for chromatographic movement of said volume of sample from said well to a liquid absorption means, said well being located adjacent to and disposed in fluid contact with said prefiltering zone of said chromatographic medium and offset upstream from said reaction sitezone, and
said liquid absorption means consisting of a quantity of blotter material disposed in fluid contact with said downstream zone of said chromatographic medium and offset downstream from said reaction sitezone.
2. The test device according to claim 1 wherein said sample application means consists of a well.
3. The test device according to claim 1 wherein said sample application means consists of an absorbent pad.
4. The test device according to claim 1 wherein said well comprises a non-removable filter.
5. The test device according to claim 1 wherein a member of a signal generating substrate/cofactor group is immobilized at said reaction zone.
6. The test device according to claim 5 wherein nitroblue tetrazolium is immobilized at said reaction zone.
7. A method for determining the presence or amount of an analyte substance in a sample which method utilizes a device comprising:
a bibulous chromatographic medium which extends throughout said device and is free of chromatographic transport-facilitating agent, defining a flowpath having capillarity and the capacity for chromatographic solvent transport of one or more non-immobilized reagents and reactive sample components; said chromatographic medium comprising (1) a prefiltering zone; (2) a reaction site zone disposed downward from said prefiltering zone at which is present containing an immobilized reagent capable of binding which specifically binds a member selected form the group consisting of said anlayte substance and labeled specific binding material, and at which the presence or amount of immobilized labeled specific binding material may be is capable of being detected and (3) a downstream zone free of said immobilized reagent disposed downstream from said reaction site zone,
a sample application means selected from the group consisting ofa single, undivided well and an absorbent paddefined by a housing element having an upper and lower portion; wherein said upper portion defines the spatial boundaries of said well and said lower portion comprises a portion of said chromatographic medium which is upstream of said prefiltering zone, said well being of sufficient capacity to hold a volume of sample for chromatographic movement from said well to a liquid absorption means, said well being located adjacent to and disposed in fluid contact with said prefiltering zone of said chromatographic materialmedium and offset upstream from said reaction sitezone, and
asaid liquid absorption means consisting of a quantity of blotter material disposed in fluid contact with said downstream zone of said chromatographicchromatographic medium and offset downstream from said reaction sitezone, said method comprising:
(a) applying a said volume of said sample sample application means to said well whereby said sample is free of chromatographic transport-facilitating agent and is transported absorbed onto said chromatographic medium at and is chromatographically transported through said prefiltering zone and along said chromatographic medium through said reaction site zone, and said downstream zone to said sample liquid absorption means,
(b) contacting said labeled specific binding material to said reaction site zone, and
(c) determining the presence or amount of said labeled specific binding material immobilized at said reaction sites zones as an indication of the presence or amount of the analyte substance in the sample.
8. The method according to claim 7 wherein unbound sample materials and unbound specific binding materials are removed from the reaction zone by means of a wash step.
9. The method according to claim 7 wherein said unlabeled specific binding material participates in a specific binding reaction with said analyte substance.
10. The method according to claim 7 wherein said reaction site zone includes an immobilized member of a signal generating substrate/cofactor group, said method further comprising the step (c′) of contacting one or more additional members of said signal generating substrate/cofactor group to said reaction site to initiate a signal generating reaction.
11. The method according to claim 10 wherein nitroblue tetrazolium is immobilized at said reaction site zone and bromochlorindolylphosphate is added to initiate a signal generating reaction.
12. A test device for determining the presence or amount of an analyte substance in a sample by means of one or more specific binding reactions comprising:
a bibulous chromatographic medium-free of chromatographic transport-facilitating agent having capillarity and the capacity for lateral chromatographic transport of one or more reactive sample components and non-immobilized reagents, said medium including a reaction zone comprising an immobilized reagent which binds a member selected from the group consisting of said analyte substance and a labeled specific binding material, said reaction zone occupying less than the entire area of the medium such that there remains an upstream portion and a downstream portion;
a single undivided well defined by a housing element comprising an upper and lower portion; wherein said upper portion defines the spatial boundaries of said well and said lower portion comprises a part of said upstream portions, said well being in fluid contact with the upstream portion of said chromatographic medium and being of sufficient capacity to retain a volume of fluid sample for chromatographic movement of said volume of sample along said chromatographic medium from said well through said reaction zone and into a liquid absorption means;
said liquid absorption means consisting of a quantity of blotter material disposed in-fluid contact with said downstream zone of said chromatographic medium.
13. The test device according to claim 1 wherein said chromatographic medium is selected from the group consisting of nitrocellulose or mixed nitrocellulose ester.
14. The method according to claim 7 wherein said chromatographic medium is selected from the group consisting of nitrocellulose or mixed nitrocellular ester.
15. The test device according to claim 14 wherein said chromatographic medium is selected from the group consisting of nitrocellulose or mixed nitrocellulose ester.
16. The test device according to claim 12 wherein said well includes a non-removable filter.
US08561215 1987-09-11 1995-11-21 Lateral flow chromatographic binding assay device Expired - Lifetime USRE39664E1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US9580187 true 1987-09-11 1987-09-11
US07355043 US4956302A (en) 1987-09-11 1989-05-15 Lateral flow chromatographic binding assay device
US94249392 true 1992-09-09 1992-09-09
US32202794 true 1994-10-12 1994-10-12
US08561215 USRE39664E1 (en) 1987-09-11 1995-11-21 Lateral flow chromatographic binding assay device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08561215 USRE39664E1 (en) 1987-09-11 1995-11-21 Lateral flow chromatographic binding assay device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US07355043 Reissue US4956302A (en) 1987-09-11 1989-05-15 Lateral flow chromatographic binding assay device

Publications (1)

Publication Number Publication Date
USRE39664E1 true USRE39664E1 (en) 2007-05-29

Family

ID=26790626

Family Applications (2)

Application Number Title Priority Date Filing Date
US07355043 Expired - Lifetime US4956302A (en) 1987-09-11 1989-05-15 Lateral flow chromatographic binding assay device
US08561215 Expired - Lifetime USRE39664E1 (en) 1987-09-11 1995-11-21 Lateral flow chromatographic binding assay device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US07355043 Expired - Lifetime US4956302A (en) 1987-09-11 1989-05-15 Lateral flow chromatographic binding assay device

Country Status (1)

Country Link
US (2) US4956302A (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110027908A1 (en) * 2009-07-31 2011-02-03 Invisible Sentinel Device for detection of antigens and uses thereof
WO2011044574A1 (en) 2009-10-09 2011-04-14 Invisible Sentinel Device for detection of antigens and uses thereof
US20110171754A1 (en) * 2007-09-14 2011-07-14 Gareth Redmond Analysis system
WO2012099897A1 (en) 2011-01-18 2012-07-26 Symbolics, Llc Lateral flow assays using two dimensional features
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
WO2013134503A2 (en) 2012-03-09 2013-09-12 Invisible Sentinel, Inc. Methods And Compositions For Detecting Multiple Analytes With A Single Signal
WO2013132338A2 (en) 2012-03-06 2013-09-12 Calpro As Competitive immunoassay for calprotectin
WO2014012077A1 (en) 2012-07-13 2014-01-16 Genisphere, Llc Lateral flow assays using dna dendrimers
WO2014015076A1 (en) 2012-07-18 2014-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US8697374B2 (en) 2008-02-28 2014-04-15 3M Innovative Properties Company Antibodies to Clostridium difficile spores and uses thereof
WO2015038978A1 (en) 2013-09-13 2015-03-19 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
US9199232B2 (en) 2010-04-07 2015-12-01 Biosensia Patents Limited Flow control device for assays
US9414813B2 (en) 2009-02-16 2016-08-16 Express Diagnostics Int'l, Inc. Device for assaying analytes in bodily fluids
WO2016164365A1 (en) 2015-04-06 2016-10-13 Bludiagnostics, Inc. A test device for detecting an analyte in a saliva sample and method of use
US9475049B2 (en) 2009-07-31 2016-10-25 Invisible Sentinel, Inc. Analyte detection devices, multiplex and tabletop devices for detection of analyte, and uses thereof
US9739773B1 (en) 2010-08-13 2017-08-22 David Gordon Bermudes Compositions and methods for determining successful immunization by one or more vaccines
WO2018039047A1 (en) 2016-08-23 2018-03-01 Qoolabs, Inc. Lateral flow assay for assessing recombinant protein expression or reporter gene expression
US10071373B2 (en) 2014-08-08 2018-09-11 Ortho-Clinical Diagnostics, Inc. Lateral-flow assay device having flow constrictions
US10088397B2 (en) 2013-06-19 2018-10-02 Advance Dx, Inc. Fluid separator collection card assembly

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
DE3887771C5 (en) 1987-04-27 2009-06-04 Inverness Medical Switzerland Gmbh Immunoassays and devices therefor.
US5912116A (en) * 1988-03-14 1999-06-15 Nextec Applications, Inc. Methods of measuring analytes with barrier webs
US5006309A (en) * 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5198368A (en) * 1988-04-22 1993-03-30 Abbott Laboratories Methods for performing a solid-phase immunoassay
EP0349215B1 (en) 1988-06-27 1995-04-12 Carter-Wallace Inc. Method and cell for detection
US5057275A (en) * 1988-09-16 1991-10-15 Exocell, Inc. Analytic reader device
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5075078A (en) * 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
US6737277B1 (en) 1989-12-18 2004-05-18 Pmb-Selfcare Llc Immunoassay devices and materials
US5279935A (en) * 1990-03-01 1994-01-18 Becton, Dickinson And Company Method of immunossay including deactivation of endogenous alkaline phosphatase
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5593844A (en) * 1990-11-19 1997-01-14 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
US5271895A (en) * 1991-02-27 1993-12-21 Boehringer Mannheim Corporation Test strip
EP0573572B1 (en) * 1991-02-27 1998-01-21 Boehringer Mannheim Corporation Improved test strip
US5877028A (en) 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5607863A (en) * 1991-05-29 1997-03-04 Smithkline Diagnostics, Inc. Barrier-controlled assay device
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5998220A (en) 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5869345A (en) 1991-05-29 1999-02-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing conductive barrier
US5468648A (en) * 1991-05-29 1995-11-21 Smithkline Diagnostics, Inc. Interrupted-flow assay device
US5686315A (en) * 1991-06-14 1997-11-11 Quidel Corporation Assay device for one step detection of analyte
US6007999A (en) * 1991-07-31 1999-12-28 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5726010A (en) * 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
WO1993015230A1 (en) * 1992-01-22 1993-08-05 Abbott Laboratories Calibration reagents for semi-quantitative binding assays and devices
US5384264A (en) * 1992-11-05 1995-01-24 Syntron Bioresearch, Inc. Method and apparatus for single step assays of ligand-containing fluids
US5547833A (en) * 1994-01-04 1996-08-20 Intracel Corporation Radial flow assay, delivering member, test kit, and methods
US6653066B1 (en) 1994-06-17 2003-11-25 Trinity Biotech Device and method for detecting polyvalent substances
GB9416002D0 (en) * 1994-08-08 1994-09-28 Univ Cranfield Fluid transport device
US6686170B1 (en) 1994-08-17 2004-02-03 Abbott Laboratories Assay devices with mobile control reagents
CA2167362A1 (en) * 1995-02-10 1996-08-11 Alexei Dmitri Klimov Apparatus and method for conducting a binding assay on an absorbent carrier material
US5668017A (en) * 1995-02-10 1997-09-16 Path Radial absorption device
US5786220A (en) * 1995-04-28 1998-07-28 Quidel Corporation Assays and devices for distinguishing between normal and abnormal pregnancy
US5739041A (en) * 1995-05-02 1998-04-14 Carter Wallace, Inc. Diagnostic detection device
US20010051350A1 (en) * 1995-05-02 2001-12-13 Albert Nazareth Diagnostic detection device and method
US5874216A (en) 1996-02-23 1999-02-23 Ensys Environmental Products, Inc. Indirect label assay device for detecting small molecules and method of use thereof
US5968839A (en) * 1996-05-13 1999-10-19 Metrika, Inc. Method and device producing a predetermined distribution of detectable change in assays
US5945345A (en) * 1996-08-27 1999-08-31 Metrika, Inc. Device for preventing assay interference using silver or lead to remove the interferant
US5871905A (en) * 1996-09-04 1999-02-16 Epitope, Inc. Reduction of false positives in oral-fluid based immunoassays
US6001658A (en) * 1996-09-13 1999-12-14 Diagnostic Chemicals Limited Test strip apparatus and method for determining presence of analyte in a fluid sample
WO1998021338A1 (en) 1996-11-08 1998-05-22 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Synthesis and purification of hepatitis c virus-like particles
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device
US5922533A (en) * 1997-08-15 1999-07-13 Abbott Laboratories Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
US6303081B1 (en) * 1998-03-30 2001-10-16 Orasure Technologies, Inc. Device for collection and assay of oral fluids
ES2264580T3 (en) * 1998-03-30 2007-01-01 Orasure Technologies, Inc. Collection device for analysis in a single step oral fluid.
US8062908B2 (en) * 1999-03-29 2011-11-22 Orasure Technologies, Inc. Device for collection and assay of oral fluids
US6140136A (en) * 1998-09-18 2000-10-31 Syntron Bioresearch, Inc. Analytical test device and method of use
US6372514B1 (en) 1998-09-18 2002-04-16 Syntron Bioresearch, Inc. Even fluid front for liquid sample on test strip device
WO2000034521A1 (en) * 1998-12-08 2000-06-15 Boston Probes, Inc. Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices
US6180417B1 (en) * 1999-04-22 2001-01-30 Bayer Corporation Immunochromatographic assay
CA2385715A1 (en) * 1999-10-06 2001-04-12 Lorenzo Williams A method for preparing and screening one or more compounds
DE10003734A1 (en) * 2000-01-28 2001-08-02 Bosch Gmbh Robert Detection method and apparatus
US6607922B2 (en) 2000-03-17 2003-08-19 Quantum Design, Inc. Immunochromatographic assay method and apparatus
EP1295122A2 (en) * 2000-05-12 2003-03-26 Rodaris Pharmaceuticals Limited Ipg assay
US6656745B1 (en) 2000-06-02 2003-12-02 Francis X. Cole Devices and methods for a multi-level, semi-quantitative immunodiffusion assay
US20020036170A1 (en) * 2000-08-11 2002-03-28 Harvey Michael A. Lateral flower plasma separation device
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US20020187564A1 (en) * 2001-06-08 2002-12-12 Caliper Technologies Corp. Microfluidic library analysis
DE60218695D1 (en) * 2001-08-09 2007-04-19 Matsushita Electric Ind Co Ltd Biosensors and measurement methods
US7875435B2 (en) * 2001-12-12 2011-01-25 Proteome Systems Ltd Diagnostic testing process
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
US20030119203A1 (en) 2001-12-24 2003-06-26 Kimberly-Clark Worldwide, Inc. Lateral flow assay devices and methods for conducting assays
US6837171B1 (en) 2002-04-29 2005-01-04 Palmer/Snyder Furniture Company Lightweight table with unitized table top
US7285424B2 (en) 2002-08-27 2007-10-23 Kimberly-Clark Worldwide, Inc. Membrane-based assay devices
US7432105B2 (en) 2002-08-27 2008-10-07 Kimberly-Clark Worldwide, Inc. Self-calibration system for a magnetic binding assay
US7640083B2 (en) 2002-11-22 2009-12-29 Monroe David A Record and playback system for aircraft
US7943395B2 (en) 2003-11-21 2011-05-17 Kimberly-Clark Worldwide, Inc. Extension of the dynamic detection range of assay devices
US7713748B2 (en) 2003-11-21 2010-05-11 Kimberly-Clark Worldwide, Inc. Method of reducing the sensitivity of assay devices
US7150995B2 (en) 2004-01-16 2006-12-19 Metrika, Inc. Methods and systems for point of care bodily fluid analysis
US20050255533A1 (en) * 2004-02-10 2005-11-17 Brendan Bioscience, Llc Comprehensive food allergy test
US20050191704A1 (en) * 2004-03-01 2005-09-01 Kimberly-Clark Worldwide, Inc. Assay devices utilizing chemichromic dyes
CN100357738C (en) * 2004-03-26 2007-12-26 博奥生物有限公司 Method of detecting small molecule compound and its special biochip
EP2299275B1 (en) 2004-07-30 2018-03-07 Adeza Biomedical Corporation Classification of the oncofetal fibronection level for pregnancy-related indications
US8128941B2 (en) * 2004-08-26 2012-03-06 Chembio Diagnostic Systems, Inc. Assay for detecting tuberculosis in nonhuman primates
US20090117660A1 (en) * 2005-04-30 2009-05-07 Oakville Hong Kong Co., Limited Devices and methods for sample collection and analysis
US7442557B1 (en) 2004-10-22 2008-10-28 Idexx Laboratories, Inc. Bi-directional flow assay device with reagent bridge
EP1655606B1 (en) * 2004-11-05 2011-08-10 F. Hoffmann-La Roche AG Biochemical assay and device
US20060177882A1 (en) * 2005-02-04 2006-08-10 Samad Talebpour Immunoassays with enhanced selectivity
US20060179901A1 (en) * 2005-02-17 2006-08-17 Schlitt Lawrence J System for preventing driving while intoxicated
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US7939342B2 (en) 2005-03-30 2011-05-10 Kimberly-Clark Worldwide, Inc. Diagnostic test kits employing an internal calibration system
JP2008541017A (en) * 2005-04-29 2008-11-20 ベックマン コールター インコーポレイテッドBeckman Coulter, Inc. Lateral flow fluorescence immunoassay
US7803319B2 (en) 2005-04-29 2010-09-28 Kimberly-Clark Worldwide, Inc. Metering technique for lateral flow assay devices
US7439079B2 (en) 2005-04-29 2008-10-21 Kimberly-Clark Worldwide, Inc. Assay devices having detection capabilities within the hook effect region
US7858384B2 (en) 2005-04-29 2010-12-28 Kimberly-Clark Worldwide, Inc. Flow control technique for assay devices
US20070042427A1 (en) * 2005-05-03 2007-02-22 Micronics, Inc. Microfluidic laminar flow detection strip
CA2608162C (en) * 2005-05-23 2013-11-12 Phadia Ab Two step lateral flow assay methods and devices
US7829347B2 (en) * 2005-08-31 2010-11-09 Kimberly-Clark Worldwide, Inc. Diagnostic test kits with improved detection accuracy
US8003399B2 (en) * 2005-08-31 2011-08-23 Kimberly-Clark Worldwide, Inc. Nitrite detection technique
US7504235B2 (en) * 2005-08-31 2009-03-17 Kimberly-Clark Worldwide, Inc. Enzyme detection technique
US7344893B2 (en) * 2005-10-13 2008-03-18 Auric Enterprises, Llc Immuno-gold lateral flow assay
US7816122B2 (en) * 2005-10-18 2010-10-19 Idexx Laboratories, Inc. Lateral flow device with onboard reagents
US20070092401A1 (en) * 2005-10-26 2007-04-26 Feier Liao Devices and methods for sample collection and analysis
US7279136B2 (en) * 2005-12-13 2007-10-09 Takeuchi James M Metering technique for lateral flow assay devices
US7618810B2 (en) 2005-12-14 2009-11-17 Kimberly-Clark Worldwide, Inc. Metering strip and method for lateral flow assay devices
US20070193934A1 (en) * 2006-01-28 2007-08-23 Shukla Ashok K Perforated surface for sample preparation
US20070202561A1 (en) * 2006-02-10 2007-08-30 Becton Dickinson And Company Electronic Detection Immunoassays that Utilize a Binder Support Medium
WO2007106579A3 (en) * 2006-03-15 2008-02-28 Micronics Inc Integrated nucleic acid assays
US20080014657A1 (en) * 2006-07-12 2008-01-17 Beckton Dickinson And Company Use of Albumin, Bovine, P-Aminophenyl N-Acetyl B-D Glucosaminide as a Control Line for an Immunoassay Device
US7749775B2 (en) * 2006-10-03 2010-07-06 Jonathan Scott Maher Immunoassay test device and method of use
US7749773B2 (en) * 2006-10-11 2010-07-06 Day Alan R Device for detection of molecules in biological fluids
US8012761B2 (en) * 2006-12-14 2011-09-06 Kimberly-Clark Worldwide, Inc. Detection of formaldehyde in urine samples
US7935538B2 (en) 2006-12-15 2011-05-03 Kimberly-Clark Worldwide, Inc. Indicator immobilization on assay devices
US8377379B2 (en) * 2006-12-15 2013-02-19 Kimberly-Clark Worldwide, Inc. Lateral flow assay device
US7846383B2 (en) * 2006-12-15 2010-12-07 Kimberly-Clark Worldwide, Inc. Lateral flow assay device and absorbent article containing same
US20090208975A1 (en) * 2007-12-13 2009-08-20 Beckman Coulter, Inc. Device and methods for detecting a target cell
EP2072529A1 (en) 2007-12-21 2009-06-24 basisnote AG MHC rapid assay used for the customization of odours
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US20110086359A1 (en) * 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
US8669052B2 (en) 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
EP2326419A1 (en) 2008-06-29 2011-06-01 Realbio Technologies Ltd. Liquid transfer device particularly useful as a capturing device in a biological assay process
US20100317033A1 (en) * 2009-06-10 2010-12-16 Matthew Philip Abdel Methods and materials for detecting food containing allergens
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US9132423B2 (en) 2010-01-29 2015-09-15 Micronics, Inc. Sample-to-answer microfluidic cartridge
US8828329B2 (en) 2010-10-01 2014-09-09 Church & Dwight, Co., Inc. Electronic analyte assaying device
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
US20130164193A1 (en) 2011-12-22 2013-06-27 Life Technologies Corporation Sequential lateral flow capillary device for analyte determination
CA2870635A1 (en) 2012-04-17 2013-10-24 Joel R. L. Ehrenkranz Device for performing a diagnostic test and methods for use thereof
CN104919191A (en) 2012-12-21 2015-09-16 精密公司 Fluidic circuits and related manufacturing methods
US8968677B2 (en) 2013-01-22 2015-03-03 Quantum Design International, Inc. Frazil ice conjugate assay device and method
CN105102980B (en) 2013-02-26 2017-11-03 阿斯图特医药公司 Having a lateral flow assay test strip holder
DE102013213279A1 (en) 2013-07-06 2015-01-08 Aj Innuscreen Gmbh Universal method for detection of various analytes
EP3126486A4 (en) 2014-04-02 2017-12-13 Chembio Diagnostic Systems, Inc. Immunoassay utilizing trapping conjugate
EP3186635A4 (en) * 2014-08-30 2018-03-07 Agency for Science, Technology And Research A test strip for paper-based assay
US9981264B2 (en) 2014-11-04 2018-05-29 Grace Bio-Labs, Inc. Nitrocellulose extrusion for porous film strips
US9927443B2 (en) 2015-04-10 2018-03-27 Conquerab Inc. Risk assessment for therapeutic drugs
US9903866B2 (en) 2016-04-05 2018-02-27 Conquerab Inc. Portable devices for detection of antibodies against therapeutic drugs
DE102016224234A1 (en) 2016-07-14 2018-01-18 Aj Innuscreen Gmbh Means and methods for detection of analytes by means of macroscopic granular particles

Citations (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723064A (en) 1971-07-26 1973-03-27 L Liotta Method and device for determining the concentration of a material in a liquid
US3915647A (en) 1974-08-16 1975-10-28 Polaroid Corp Device for determining the concentration of a substance in a fluid
US4094647A (en) * 1976-07-02 1978-06-13 Thyroid Diagnostics, Inc. Test device
US4168146A (en) 1975-01-27 1979-09-18 Ab Kabi Immunoassay with test strip having antibodies bound thereto
US4189304A (en) 1978-10-27 1980-02-19 Miles Laboratories, Inc. Device and method for detecting myoglobin
US4235601A (en) * 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4255575A (en) 1979-05-04 1981-03-10 Richardson-Merrell Inc. 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives
US4271119A (en) 1979-07-23 1981-06-02 Eastman Kodak Company Capillary transport device having connected transport zones
US4323536A (en) 1980-02-06 1982-04-06 Eastman Kodak Company Multi-analyte test device
US4361537A (en) * 1979-01-12 1982-11-30 Thyroid Diagnostics, Inc. Test device and method for its use
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
EP0088636A2 (en) 1982-03-09 1983-09-14 Bio-Metrics Systems, Inc. Quantitative analysis apparatus and method
EP0168689A2 (en) * 1984-07-16 1986-01-22 Abbott Laboratories Immunoassay for detection of common determinant antibody to hepatitis B
EP0183442A2 (en) 1984-11-15 1986-06-04 Syntex (U.S.A.) Inc. Chromatographic device and method
US4623461A (en) 1985-05-31 1986-11-18 Murex Corporation Transverse flow diagnostic device
US4678757A (en) 1985-04-11 1987-07-07 Smithkline Diagnostics, Inc. Device and method for whole blood separation and analysis
US4693834A (en) 1986-05-05 1987-09-15 Murex Corporation Transverse flow diagnostic kit
EP0262328A2 (en) 1986-09-29 1988-04-06 Abbott Laboratories Chromatographic test strip for determining ligands and receptors
US4740468A (en) * 1985-02-14 1988-04-26 Syntex (U.S.A.) Inc. Concentrating immunochemical test device and method
EP0267006A2 (en) 1986-11-07 1988-05-11 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US4748115A (en) * 1986-01-08 1988-05-31 Abbott Laboratories Substrate formulation in 2-amino-2-methyl-1-propanol buffer for alkaline phosphatase assays
US4761381A (en) 1985-09-18 1988-08-02 Miles Inc. Volume metering capillary gap device for applying a liquid sample onto a reactive surface
WO1988008534A1 (en) 1987-04-27 1988-11-03 Unilever Plc Immunoassays and devices therefor
EP0296724A2 (en) 1987-06-01 1988-12-28 Quidel Assay and apparatus using a lateral flow, non-bibulous membrane
EP0322340A2 (en) 1987-12-16 1989-06-28 Disease Detection International Inc., Bi-directional lateral chromatographic test device
US4861711A (en) * 1984-12-15 1989-08-29 Behringwerke Aktiengesellschaft Sheet-like diagnostic device
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US4956275A (en) * 1987-04-14 1990-09-11 Molecular Devices Corporation Migratory detection immunoassay
US4981786A (en) * 1987-09-04 1991-01-01 Syntex (U.S.A.) Inc. Multiple port assay device
US5079142A (en) * 1987-01-23 1992-01-07 Synbiotics Corporation Orthogonal flow immunoassays and devices
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723064A (en) 1971-07-26 1973-03-27 L Liotta Method and device for determining the concentration of a material in a liquid
US3915647A (en) 1974-08-16 1975-10-28 Polaroid Corp Device for determining the concentration of a substance in a fluid
US4168146A (en) 1975-01-27 1979-09-18 Ab Kabi Immunoassay with test strip having antibodies bound thereto
US4094647A (en) * 1976-07-02 1978-06-13 Thyroid Diagnostics, Inc. Test device
US4189304A (en) 1978-10-27 1980-02-19 Miles Laboratories, Inc. Device and method for detecting myoglobin
US4235601A (en) * 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4361537A (en) * 1979-01-12 1982-11-30 Thyroid Diagnostics, Inc. Test device and method for its use
US4255575A (en) 1979-05-04 1981-03-10 Richardson-Merrell Inc. 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives
US4271119A (en) 1979-07-23 1981-06-02 Eastman Kodak Company Capillary transport device having connected transport zones
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4323536A (en) 1980-02-06 1982-04-06 Eastman Kodak Company Multi-analyte test device
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4366241B1 (en) * 1980-08-07 1988-10-18
EP0088636A2 (en) 1982-03-09 1983-09-14 Bio-Metrics Systems, Inc. Quantitative analysis apparatus and method
EP0168689A2 (en) * 1984-07-16 1986-01-22 Abbott Laboratories Immunoassay for detection of common determinant antibody to hepatitis B
EP0183442A2 (en) 1984-11-15 1986-06-04 Syntex (U.S.A.) Inc. Chromatographic device and method
US4861711A (en) * 1984-12-15 1989-08-29 Behringwerke Aktiengesellschaft Sheet-like diagnostic device
US4740468A (en) * 1985-02-14 1988-04-26 Syntex (U.S.A.) Inc. Concentrating immunochemical test device and method
US4678757A (en) 1985-04-11 1987-07-07 Smithkline Diagnostics, Inc. Device and method for whole blood separation and analysis
US4623461A (en) 1985-05-31 1986-11-18 Murex Corporation Transverse flow diagnostic device
US4761381A (en) 1985-09-18 1988-08-02 Miles Inc. Volume metering capillary gap device for applying a liquid sample onto a reactive surface
US4748115A (en) * 1986-01-08 1988-05-31 Abbott Laboratories Substrate formulation in 2-amino-2-methyl-1-propanol buffer for alkaline phosphatase assays
US4693834A (en) 1986-05-05 1987-09-15 Murex Corporation Transverse flow diagnostic kit
US4960691A (en) * 1986-09-29 1990-10-02 Abbott Laboratories Chromatographic test strip for determining ligands or receptors
EP0262328A2 (en) 1986-09-29 1988-04-06 Abbott Laboratories Chromatographic test strip for determining ligands and receptors
EP0267006A2 (en) 1986-11-07 1988-05-11 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5030558A (en) * 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5079142A (en) * 1987-01-23 1992-01-07 Synbiotics Corporation Orthogonal flow immunoassays and devices
US4956275A (en) * 1987-04-14 1990-09-11 Molecular Devices Corporation Migratory detection immunoassay
WO1988008534A1 (en) 1987-04-27 1988-11-03 Unilever Plc Immunoassays and devices therefor
EP0296724A2 (en) 1987-06-01 1988-12-28 Quidel Assay and apparatus using a lateral flow, non-bibulous membrane
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US4981786A (en) * 1987-09-04 1991-01-01 Syntex (U.S.A.) Inc. Multiple port assay device
EP0322340A2 (en) 1987-12-16 1989-06-28 Disease Detection International Inc., Bi-directional lateral chromatographic test device

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171754A1 (en) * 2007-09-14 2011-07-14 Gareth Redmond Analysis system
US8835184B2 (en) 2007-09-14 2014-09-16 Biosensia Patents Limited Analysis system
US8697374B2 (en) 2008-02-28 2014-04-15 3M Innovative Properties Company Antibodies to Clostridium difficile spores and uses thereof
US10076314B2 (en) 2009-02-16 2018-09-18 Express Diagnostics Int'l, Inc. Device for assaying analytes in bodily fluids
US9414813B2 (en) 2009-02-16 2016-08-16 Express Diagnostics Int'l, Inc. Device for assaying analytes in bodily fluids
US9462998B2 (en) 2009-02-16 2016-10-11 Express Diagnostics Int'l, Inc. Device for assaying analytes in bodily fluids
US8183059B2 (en) 2009-07-31 2012-05-22 Invisible Sentinel, Inc. Device for detection of target molecules and uses thereof
US8476082B2 (en) 2009-07-31 2013-07-02 Invisible Sentinel, Inc. Device for detection of target molecules and uses thereof
US9475049B2 (en) 2009-07-31 2016-10-25 Invisible Sentinel, Inc. Analyte detection devices, multiplex and tabletop devices for detection of analyte, and uses thereof
US8012770B2 (en) 2009-07-31 2011-09-06 Invisible Sentinel, Inc. Device for detection of antigens and uses thereof
US9341624B2 (en) 2009-07-31 2016-05-17 Invisible Sentinel, Inc. Device for detection of target molecules and uses thereof
US9816984B2 (en) 2009-07-31 2017-11-14 Invisible Sentinel, Inc. Device for detection of target molecules and uses thereof
US20110027908A1 (en) * 2009-07-31 2011-02-03 Invisible Sentinel Device for detection of antigens and uses thereof
US9557330B2 (en) 2009-10-09 2017-01-31 Invisible Sentinel, Inc. Device for detection of analytes and uses thereof
WO2011044574A1 (en) 2009-10-09 2011-04-14 Invisible Sentinel Device for detection of antigens and uses thereof
US9199232B2 (en) 2010-04-07 2015-12-01 Biosensia Patents Limited Flow control device for assays
US9739773B1 (en) 2010-08-13 2017-08-22 David Gordon Bermudes Compositions and methods for determining successful immunization by one or more vaccines
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
EP3187876A1 (en) 2011-01-18 2017-07-05 Symbolics, LLC Lateral flow assays using two dimensional features
US9874576B2 (en) 2011-01-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
WO2012099897A1 (en) 2011-01-18 2012-07-26 Symbolics, Llc Lateral flow assays using two dimensional features
US9851366B2 (en) 2011-01-18 2017-12-26 Symbolics, Llc Lateral flow assays using two dimensional features
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
WO2013132338A2 (en) 2012-03-06 2013-09-12 Calpro As Competitive immunoassay for calprotectin
US10018626B2 (en) 2012-03-09 2018-07-10 Invisible Sentinel, Inc. Methods and compositions for detecting multiple analytes with a single signal
WO2013134503A2 (en) 2012-03-09 2013-09-12 Invisible Sentinel, Inc. Methods And Compositions For Detecting Multiple Analytes With A Single Signal
US9347938B2 (en) 2012-03-09 2016-05-24 Invisible Sentinel, Inc. Methods for detecting multiple analytes with a single signal
US9823240B2 (en) 2012-03-09 2017-11-21 Invisible Sentinel, Inc. Methods and compositions for detecting multiple analytes with a single signal
US9651549B2 (en) 2012-07-13 2017-05-16 Genisphere, Llc Lateral flow assays using DNA dendrimers
WO2014012077A1 (en) 2012-07-13 2014-01-16 Genisphere, Llc Lateral flow assays using dna dendrimers
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
WO2014015076A1 (en) 2012-07-18 2014-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US9599615B2 (en) 2013-03-13 2017-03-21 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
US10088397B2 (en) 2013-06-19 2018-10-02 Advance Dx, Inc. Fluid separator collection card assembly
WO2015038978A1 (en) 2013-09-13 2015-03-19 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
US10071373B2 (en) 2014-08-08 2018-09-11 Ortho-Clinical Diagnostics, Inc. Lateral-flow assay device having flow constrictions
WO2016164365A1 (en) 2015-04-06 2016-10-13 Bludiagnostics, Inc. A test device for detecting an analyte in a saliva sample and method of use
WO2018039047A1 (en) 2016-08-23 2018-03-01 Qoolabs, Inc. Lateral flow assay for assessing recombinant protein expression or reporter gene expression

Also Published As

Publication number Publication date Type
US4956302A (en) 1990-09-11 grant

Similar Documents

Publication Publication Date Title
US5468648A (en) Interrupted-flow assay device
US6737278B1 (en) Ligand binding assay and kit with a separation zone for disturbing analytes
US5753517A (en) Quantitative immunochromatographic assays
US5166051A (en) Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes
US6514773B1 (en) Method of detecting surface contamination by an analyte
US5716778A (en) Concentrating immunochemical test device and method
US5362654A (en) Self-contained quantitative assay
US6716641B1 (en) Dipstick for carbohydrate-free transferrin assay
US4774192A (en) A dry reagent delivery system with membrane having porosity gradient
US5219762A (en) Method and device for measuring a target substance in a liquid sample
US6228660B1 (en) Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4959307A (en) Immunoseparating strip
US4826759A (en) Field assay for ligands
US5141850A (en) Porous strip form assay device method
US5712172A (en) One step immunochromatographic device and method of use
US5998220A (en) Opposable-element assay devices, kits, and methods employing them
US6303081B1 (en) Device for collection and assay of oral fluids
US6528323B1 (en) Bidirectional lateral flow test strip and method
US4806311A (en) Multizone analytical element having labeled reagent concentration zone
US5939331A (en) Red blood cell separation means for specific binding assays
US4587102A (en) Multi-layer analysis element utilizing specific binding reaction
US5200321A (en) Microassay on a card
US5149622A (en) Solid phase analytical device and method for using same
US4870005A (en) Multilayer analysis element
US5726010A (en) Reversible flow chromatographic binding assay